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~oteogly~ans synih~sized by articutar and ep~physeal chondrocytes in culture were compared. 
~roteogly~ns extruded by the two types of ceils into the culture medium are of identicaf M,. On the other 
hand, the proteoglycans of cells or pericellular matrix synthesized by the articular chondrocytes are 
characterized by an heterogeneous fraction of low-M, which is not present in the material derived from 
epiphyseal chondrocytes. There are at feast two components in this fraction: the first seems to be a 
precursor of aggregated proteoglycans, the other may represent a component of cell coat. Stimulation of 
the cell cultures with vitamin D metabolites and somatomedin enhances proteogiycan biosynthesis but no 
modification is observed in the proteoglycan M,. 
1. INTRODUCTION 
The chemical composition, M,, aggregation 
ability and rheological properties of proteoglycans 
from calcifying and nou-~al~if~ug cartilages, 
either normal or pathologist, have been extensive- 
ly investigated in the last few years in an attempt 
to understand better the mechanism of calcifica- 
tion [1,2]. 
Proteoglycan production is also the phenotype 
expression of cultured chondrocytes, the amount 
and species of proteoglycans synthesized being 
under the influence of various factors fex- 
tracellular concentration of prot~~lycans, hor- 
mones, drugs, metabolite concentration. . ) t3-93, 
No comparison has been made so far, however, 
between the characteristics of proteoglycans syn- 
thesized in vitro by mature chondrocytes derived 
from epiphyseal, pre-osseous cartilage and those 
synthesized by chondrocytes of articular, hyaline 
con-falsifying cartilage. 
The in vitro biology of the two types of cells in 
primary culture is quite different. For example, 
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they reach confluence after different periods of 
time and the distribution of cells in culture flasks 
is different, articular chondrocytes being organiz- 
ed as a monolayer [lOI and epiphyseal chon- 
drocytes as multiIayered colonies [I I]. 
Finally, the electrophoretic properties of pro- 
teogfycans subunits synthesized and secreted by 
each type of cultured chondrocytes are different 
[12]” 
Cultures of the two types of chondrocytes pro- 
vide useful model systems for use in the investiga- 
tion of the biochemistry of calcification. 
Here, we demonstrate that the two types of celis 
synthesize different pools of prot~gly~ns and 
that the low-M, proteoglycans pecific of articular 
cho~droc~es represent at least two different types 
of molecules. One of these is a precursor of ag- 
gregated proteoglycans, the other may be a compo- 
nent of articular chondrocytes glycocalix. 
2. MATERIALS AND METHYLS 
Procedures for isolation and culture of chon- 
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drocytes from articular and growth plate cartilage 
of Fauve de Bourgogne young rabbits have been 
described in [lo] and [l I], respectively. Thin slices 
of articular and growth plate cartilage were gently 
scrapped from the upper end of the tibiae under 
sterile conditions, and digested separately with 
0.2% hyaluronidase, 0.5% trypsin (Worthington) 
and 0.5% clostridial collagenase (Boehringer) in 
Gey’s balanced salt solution. A pure chondrocyte 
suspension was obtained and incubated to large 
culture flasks (75 cm’) each containing 12 ml 
Dulbecco’s medium (Gibco-Flobio) supplemented 
with 10% fetal calf serum (FCS) 0.1 unit/ml 
penicillin and 0.1 pg/ml streptomycin. 
hibitors (10 mM Na2 EDTA, 5 mM benzamidine, 
0.1 mM 6-aminohexanoic acid). The whole 
purification process was then performed essential- 
ly as in [13]. Briefly after centrifugation at 3600 x 
g, the material was washed with 5 ml 0.1 M 
Na2S04 and dissolved in 2 ml of 1.25 M MgC12. 
After centrifugation, the supernatant was 
reprecipitated with 8 ml ice-cold ethanol and left at 
4°C overnight. The pellet was then stored 
lyophilized. 
The final concentration was 3.5 x lo5 
tells/75-cm’ flask. The flasks were gassed with 
10% CO2 in air and maintained at 37°C. The 
medium was then changed 3-times/week until the 
cells stopped dividing. The stationary phase was 
reached after 9 or 21 days in culture for articular 
chondrocytes and growth plate chondrocytes, 
respectively. At that phase of the cell cycle each 
type of chondrocyte, in triplicate flasks, was 
deprived of FCS for 24 h and the medium was then 
replaced with fresh serum-free medium containing 
Na23’S04 (1.5 &i/ml) (Amersham-France, Les 
Ulis). Cells were further incubated at 37°C for 
20 h for long-term labelling, or for 15 min, 30 min 
and 60 min for pulse-labelling in the presence or 
absence of 1,25-(OH)&, 24,25-(OH)zDs 
(lO_” M) (gifts from Dr M. Garabedian, CNRS 
ER 126, Paris) or a somatomedin peptide with 
Insulin-like activity referred to as ILAs (10 ng/ml) 
(purified by H. Guyda and B. Posner at McGill 
University, Montreal), or 2010 FCS. Cells and 
media were then separately studied. 
Proteoglycans were also obtained from cell 
monolayers or colonies by dissociative extraction 
with 3 M guanidinium hydrochloride in 50 mM 
Tris-HCI, pH 7.4 (5 m1/75-cm2 Falcon flask) for 
48 h at 0°C in the presence of protease inhibitors. 
The extracts were clarified by centrifugation at 
3000 x g for 10 min, and then proteoglycans were 
precipitated with CPC at a final concentration of 
lcr/o. The CPC precipitates were then treated as in 
P31. 
For some preliminary experiments pro- 
teoglycans were extracted from articular and 
epiphyseal cartilage by gentle soaking of the tissue 
slices in 4 M guanidinium hydrochloride 0.05 M 
Tris-HCI (pH 7.4) containing protease inhibitors, 
for 48 h at room temperature. The extracts were 
then extensively dialyzed against distilled water 
and made up with 0.5 M sodium acetate (pH 6.8) 
at the moment of gel filtration. 
2.3. Gel filtration 
Media from long-term labelling were treated as 
described under proteoglycan extraction and 
purification. Media from short-term pulse ex- 
periments were discarded. In all cases, cells were 
gently washed and chased with fresh medium con- 
taining 1 mM non-radioactive sulphate. This 
medium was removed prior to extracting the pro- 
teoglycans from the cell pellet. 
Lyophilized proteoglycans were dissolved in 
0.5 M sodium acetate (pH 6.8) and aliquots of 
100-200~1 (20-100 fig of uranic acid) were ap- 
plied to columns of Sepharose 2B or CL 6B (0.5 x 
65 cm) preequilibrated in the same buffer in the 
absence or presence of an excess of non- 
radioactive carrier. 
Proteoglycan elution was performed in 
associative condition with 0.5 M sodium acetate 
(pH 6.8) at a flow rate of 2.5 ml/h. Fractions of 
0.4 ml were collected and the radioactivity and 
uranic acid content of each fraction were deter- 
mined by scintillation counting and the carbazole 
assay as in [14], respectively. 
2.2. Proteoglycan extraction and purification 
At confluency, the medium from two 75-cm’ 2.4. Analytical procedures 
flasks was pooled (28 ml) and proteoglycans were Uranic acid content of samples or fractions was 
extracted by adding 7 ml 5% cetylpyridinium measured as in [ 141; hexosamines were determined 
chloride (CPC) in the presence of protease in- by a micro-modification of the Elson-Morgan 
188 
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reaction as in [ 151, hexoses by the method in [ 161 
and protein by the method in [17]. 
Conventional polyacrylamide slab gel elec- 
trophoresis was performed on 10% acrylamide gels 
in 0.1 M Tris-glycine buffer (pH 8.9). 
Gels were stained for proteins with Coomassie 
Blue as described in [18] and for 
glycosaminoglycans with Toluidine Blue in 0.1 M 
acetate buffer (pH 4.5) after fixation in 10% 
trichloroacetic acid. 
Statistical analysis was done by calculating the 
mean + standard deviation (SD). The significance 
of differences was evaluated by Student’s t-test. 
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3. RESULTS 
3.1. Pattern of proteoglycans synthesized by 
articular and growth plate chondrocytes at 
different stages of the culture 
Gel filtration was the experimental approach 
selected for studying the characteristics of pro- 
teoglycans synthesized by the two types of cells. 
Preliminary experiments were carried out with 
proteoglycans extracted with 4 M guanidinium 
hydrochloride from articular and epiphyseal car- 
tilage of young rabbits. Their gel permeation pro- 
files were compared with those of the pro- 
teoglycans purified from the culture media of the 
corresponding cells maintained in culture. Under 
associative conditions the elution patterns of pro- 
teoglycans synthesized in vivo (fig.lA) were 
superimposable on those of proteoglycans syn- 
thesized in vitro only when cells in culture were in 
the stationary phase (fig.lC). The aggregating 
ability of a proteoglycan extract from dividing 
cultured chondrocytes appears completely abnor- 
mal (fig.lB). For this reason, the experiments 
presented here were always carried out on cultures 
of articular and epiphyseal chondrocytes at the 
9th, 10th and 21st day of incubation, respectively. 
Two pools of proteoglycans were considered: 
(i) Proteoglycans of culture media; and 
(ii) Cell proteoglycans, a composite fraction con- 
taining proteoglycans localized at the level of 
chondrocyte coat, in intracellular organels and 
in the pericellular matrix. 
5 10 15 
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Fig.1. Elution profiles of hexuronic acid from a 
Sepharose 2B column under associative conditions after 
application of proteoglycans purified from: (A) articular 
(- - -) and epiphyseal (-) cartilage of young rabbits; 
(B) culture media of articular and epiphyseal 
chondrocytes at the 6th and 13th day of culture, 
respectively; (C) culture media of articular and 
epiphyseal chondrocytes at the 9th and 21st day of 
culture, respectively. Proteoglycans were extracted with 
4 M guanidinium hydrochloride, 0.05 M Tris-HCl (pH 
7.4) and purified as described in detail in section 2. 
Aliquots containing 20-lOO pug uranic acid were 
chromatographed on a Sepharose 2B column (see section 
2). V0 is the void volume of the column. 
side) independently of the origin of the 
chondrocytes. 
On the contrary, cell proteoglycans are not iden- 
tical (fig.2A and B, left side). In fact, in the case 
of the material derived from articular chon- 
drocytes, besides the peaks of aggregated pro- 
teoglycans and proteoglycan subunits, there is a 
retarded fraction eluted with the total volume of 
the column. 
A similar profile is obtained when articular 
chondrocytes proteoglycans are purified without 
treatment of cell fraction with 3 M guanidinium 
hydrochloride by direct precipitation with 1% 
CPC and ethanol [13]. 
Proteoglycans purified from culture media ex- This peak is never present in the material derived 
hibit nearly identical elution patterns in associative from growth plate cells. 
conditions from Sepharose 2B (fig.2A and B, right Treatment of cultures of the two types of cells by 
189 
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CELLS MEDIUM 
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Fig.2. Sepharose 2B elution profiles of “S-labelled 
proteoglycans purified from cell fraction and culture 
media of confluent cultures of epiphyseal (A) and 
articular (B) chondrocytes. Confluent cultures of 
epiphyseal and articular chondrocytes were labelled with 
Naz3’S04 (1.5 &i/ml for 20 h) as described in the text. 
Proteoglycans were then extracted separately from the 
medium and from the cell pellet with 3 M guanidinium 
hydrochloride (see section 2). Samples containing about 
3000-8000 dpm for cell pellet and 
150 000-200000 dpm for culture medium of “S- 
labelled proteoglycans were applied to a column of 
Sepharose 2B and chromatographed as described in the 
text. Recovery of radioactivity from the column was 
greater than 85% in each case. VO is the void volume; V, 
is the total volume of the column. 
either vitamin D metabolites (1,25-(OH)zD3 or 
24,25-(OH)zD$ somatomedin (ILAs) or FCS, does 
not modify the hydrodynamic properties of pro- 
duced proteoglycans (not shown). 
3.2. Pulse-labelling of proteoglycans synthesized 
by cultured articular chondrocytes 
Culture chondrocytes were incubated in the 
presence of [35S]sulphate for different periods of 
time (15 min, 30 min or 60 min) and proteoglycans 
extracted from the cellular pool were analyzed by 
chromatography on Sepharose 2B column in the 
absence or presence of non-radioactive carrier. 
After 15 min labelling, most of the radioactivity 
extracted from the cellular pool and 
chromatographed in the absence of carrier is eluted 
as the retarded fraction previously described 
(fig.3A). When chromatographed in the presence 
of carrier, the elution profile is mainly composed 
of a large peak of proteoglycan aggregates and 
5 10 15 
Elution volume (ml) 
Fig.3. Sepharose 2B elution patterns of 35S-labelled 
proteoglycans from cell fraction of articular 
chondrocytes. Confluent cultures of articular 
chondrocytes were labelled with Na235S04 (1.5 &i/ml) 
with a 15-min pulse. Proteoglycans were extracted with 
3 M guanidinium hydrochloride from the cell layer. 
Samples of cellular extracts containing 4000 dpm of 35S- 
labelled proteoglycans were applied to Sepharose 2B 
columns in the absence (A), or in the presence(B) of non- 
radioactive carrier. Recovery of radioactivity from the 
column was always greater than 85%. V, is the void 
volume; V, is the total volume of the column. Shaded 
areas represent low-M, proteoglycans. 
subunits with, to a smaller extent, the retarded 
peak (fig.3B). A similar profile was obtained after 
30 min and 60 min labelling. 
In this last case, the relative percentage of the re- 
maining retarded peak compared with the total 
radioactivity extracted from the cellular pool and 
applied to the column is about lo- 15%. 
After labelling for 20 h the relative percentage 
of the retarded peak is about 30% of the applied 
radioactivity. A chase of 1 h or 4 h drastically 
reduces the amount of retarded material to 
lo- 15 ‘70 of the total applied radioactivity. The elu- 
tion profile is then similar to fig.3B. 
Again, no modification of these elution profiles 
is observed when the chondrocytes are treated with 
1,25-(OH)zDj, 24,25-(OH)2D3 (10-l’ M), ILAs 
(10 ng/ml), or fetal calf serum (2%) whereas the 
total [3’S]sulphate uptake in the cellular extract as 
well as in the medium is increased as shown in 
table 1. 
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Table 1 
[35S]Sulphate uptake in proteoglycans extracted from 
the cellular pool of cultured articular chondrocytes 
[3’S]Sulphate uptake in cellular 
proteoglycans (dpm/pg DNA) 
Pulse labelling 15 min 20 h 
(x 10-2) (x 10-4) 
Control 3.17 f 0.03 2.14 f 0.50 
FCS 4.05 rf: o.02c 5.26 * 0.26b 
24,25-(OH)zDs 4.00 f 0.03c 3.80 f 0.47a 
1.25(0H)zDs 4.12 + 0.02’ 4.24 k 0.16b 
ILAs 4.07 f o.02c 4.20 -+ O.SO* 
a 0.01 < p < 0.05 
b 0.001 < p < 0.01 
‘p<O.OOl 
Confluent articular chondro~ytes were incubated with 
1.5 &i/ml Na2?S04 for 15 min or 20 h. The cells were 
rinsed 3-times with buffer. Proteoglycans were then 
extracted with 3 M guanidinium hydrochloride and 
precipitated with CPC and finally dissolved in 1.25 M 
MgC12. Samples were then counted in a Packard Tri- 
carb and the radioactivity was expressed as dpm/& 
DNA. In the control group, the number of identical 
flasks is n = 5, in each treated group n = 4 
3.3. Characterization of the material of the 
retarded peak 
The material contained in the retarded fraction, 
when rechromatographed on Sepharose CL 6B 
(fractionation limits for polysaccharides 
106-lo4 II;%), appears with the inner volume of the 
column as a composite peak (fig.4). At least two 
components are present in the fraction: the fast 
moving one has a Kav of 0.36, the slowest a Kay of 
0.74. If compared with the Kay of globular proteins 
as i% standards, within the limits of this com- 
parison, one may extrapolate for the fast compo- 
nent an M, of 300000, and for the other an it4, of 
16000. 
The chemical analysis of this fraction indicates 
that it is composed of proteins and carbohydrates: 
expressedimg proteins it contains 0.14 mg 
uronate, 0.15 mg hexosamines and 2.45 mg hex- 
oses. The ratio between hexosamines and uronate 
is close to 1 and suggests the presence of chon- 
droitin sulphates but there is an abnormal eleva- 
tion of neutral sugars. These quantitative results 
5 10 15 
Elution volume (ml) 
Fig.4. Chromatography on Sepharose 6B column, of 
35S-labelled proteoglycan material eluted as a retarded 
peak on Sepharose 2B column. Confluent articular 
chondrocytes were iabelled with Na2’%04 for 20 h as 
described in the legend of fig.2. 3’S-Labelled 
proteogIycans were extracted from the cells with 3 M 
guanidinium hydrochloride (see section 2). Radioactivity 
(10000 dpm) was applied to Sepharose 2B columns and 
the 33S-labelled material eluted as a retarded peak was 
then chromatographed on Sepharose 6B column. 
Recovery of radioactivity from the column was 90%. V, 
is the void volume; V, is the total volume of the column. 
$ 
0 
I 
0 
mg.mg prot-’ 
Uronate 0.14f0.07 
Hexosamines 0.15*0.08 
Hexoses 2.45AO.65 
Fig.5. Schematic representation of polyacrylamide slab 
gel electrophoresis. Staining was performed with 
Coomassie Blue for proteins and with Toluidine Blue for 
glycos~inoglycans. 
are not consistent with the hypothesis of a single 
type of molecule. Similarly, electrophoresis ex- 
periments reveal that this fraction is not 
homogeneous. Three bands appear on 10% 
polyacryIamide gels which stain with Coomassie 
Blue and metachromatically with Toluidine Blue, 
pH 4.5 (fig.5). The low spec. act. of the tracer 
precludes a correct quantification of the radioac- 
tivity present in each band. 
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4. DISCUSSION 
It is well known that in cell and tissue cultures 
the biosynthetic activity of chondrocytes is 
markedly influenced by the composition of the ex- 
tracellular environment. Matrix depletion 
[3,19,20], the presence of variable amounts of 
hyaluronic acid WI, proteoglycans, 
glycosaminoglycans [4] in the medium may 
modulate proteoglycan production by the cells and 
the proteoglycan size [21]. 
In fact, the results reported in fig.1 show that 
hydrodynamic size of proteoglycans freely diffus- 
ed in culture medium, are strictly correlated to 
those of proteoglycans synthesized in vivo and 
secreted into the matrix only when cells in cultures 
are in the stationary phase. It is an important point 
to have cell cultures producing constantly the same 
type of macromolecules especially if some ex- 
trapolation in vivo will be made from the data ob- 
tained in vitro. 
The results illustrated in fig.2B point out the ex- 
istence of a pool of sulphated macromolecules of 
low-M, specific of articular chondrocytes. 
This retarded fraction may contain - at least in 
part - either a definitive material, possibly a 
precursor of other macromolecules or complexes, 
or a degradative product of cell metabolism. 
Part of our data may support both hypotheses 
since stimulating protein synthesis with vitamin D 
metabolites, somatomedin or FCS increases the 
total [35S]sulphate uptake, whereas no difference 
in the elution pattern of proteoglycan is observed. 
But other data such as pulse-chase experiments 
give evidence for the first hypothesis. After short- 
pulses of [35S]sulphate he shifting of the label in 
the presence of carrier from the region of low 
hydrodynamic size to the region of aggregated 
material, demonstrates that a part of the material 
of the retarded peak is a ‘precursor’ of aggregated 
proteoglycans (fig.3). There are other reasons to 
exclude the possibility that this fraction is a 
degradative product. Proteoglycans derived from 
chondrocytes of growth plate, where degradative 
enzymes are more active, as shown in [22,23], do 
not contain this fraction. Furthermore, the whole 
purification procedure is carried out in the 
presence of inhibitors of hydrolytic enzymes. 
In addition, the retarded fraction does not seem 
to be homogeneous. Gel sieving chromatography 
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reveals that it is a composite fraction; acrylamide 
gel electrophoresis reveals 3 bands, all of which 
stain with the dyes of proteins and those of 
glycosaminoglycans. Chemical analysis shows that 
there is a uronate/hexosamine ratio characteristic 
of chondroitin sulphate (close to the unity) but that 
an abnormally high quantity of neutral sugars 
(hexoses) is also present. All these results suggest 
the existence of at least two pools of molecules in 
the retarded fraction observed in articular chon- 
drocytes in vitro. The first, characterized by a 
uronate/hexosamine ratio of 1, may be the precur- 
sor of high-M, proteoglycans. The other, 
characterized by a high hexose/protein ratio, is 
probably a glycoprotein component of the cell coat 
and/or structural glycoprotein from the ex- 
tracellular matrix. 
The difference between the elution pattern of 
labelled cellular proteoglycans of a 15-60 min 
pulse (fig.3) and that of a 20-h pulse (fig.2B) clear- 
ly indicates that a long pulse period, without 
renewal of the culture medium, causes an ac- 
cumulation of low-M, macromolecules (retarded 
peak) which represents about 35% of total 
radioactive compounds. 
Since it was shown [24] that proteoglycans are 
secreted by the cells in the monomeric form at the 
same time as link proteins and hyaluronic acid, one 
may assume that the aggregated form of pro- 
teoglycans is present in the pericellular matrix and 
in the culture medium, while the low-M, pro- 
teoglycans remain associated with articular chon- 
drocytes. During a prolonged stimulus (20-h pulse) 
an inhibition of the secretory vacuoles is probably 
favoured by the modification of the medium and 
pericellular environment. 
The renewal of culture medium for various times 
of chase promotes the secretion of proteoglycans 
to the pericellular matrix where aggregation occurs 
immediately. Since the amount of total radioactivi- 
ty extracted from the cell pellet does not change for 
the various times of chase, one may suggest he 
transformation of ‘small molecules into aggregates 
of proteoglycans’. The persistence of 10-15’70 of 
the radioactivity in low-M, molecules indicates that 
a portion of the total proteoglycans is never ex- 
ported from the cells. The possibility may be con- 
sidered that this lo-15% of radioactivity is 
associated with some components of the glycopro- 
tein coat of articular chondrocytes. 
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The fact that the retarded peak of proteoglycans 
has never been demonstrated in growth plate chon- 
drocytes may be because: 
(i) The pathways of extrusion and assembling of 
proteoglycans from the two types of cells are 
different; 
(ii) The kinetics of extrusion are different; 
(iii) Proteoglycans synthesized in vitro by the two 
types of cells are different, as in the case of rat 
chondrosarcoma described in [24]. 
In all these cases, the differences may have some 
relevance in the physiological functions that these 
cells exert in vivo; i.e., the biosynthesis of a 
calcifiable matrix. 
These differences may also be the expression of 
a regulatory role of the proteoglycans on cell-cell 
recognition. 
The presence of a fraction of low-i% in chon- 
drocytes of the articular cartilage may be responsi- 
ble for their monolayer distribution in culture 
flasks and the lack of this fraction in epiphyseal 
chondroc~es may permit their organization in 
colonies. 
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